References
- Nagarwal RC, Ridhurkar DN, Pandit, JK. (2010). In vitro release kinetics and bioavailability of gastroretentive cinnarizine hydrochloride tablet. AAPS Pharm Sci Tech, 11:294–303.
- Talukder R, Fassihi R. (2004). Gastroretentive delivery systems: a mini review. Drug Dev Ind Pharm, 30:1019–1028.
- El Gamal SS, Naggar VF, Allam AN. (2011). Optimization of acyclovir oral tablets based on gastroretention technology: factorial design analysis and physicochemical characterization studies. Drug Dev Ind Pharm, 37:855–867.
- Lu X, Wang J. (2003). [Advances in the study of Bergenia plants]. Zhong Yao Cai, 26:58–60.
- Li F, Zhou D, Qin X, Zhang Z, Huang Y. (2009). Studies on the physicochemical properties of bergenin. Chin Pharm J, 44:92–95.
- Qin X, Yuan F, Zhou D, Huang Y. (2010). Oral characteristics of bergenin and the effect of absorption enhancers in situ in vitro and in vivo. Arzneimittel-Forschung, 60:198–204.
- Mahdy AM, Webster NR. (2008). Histamine and antihistamines. Anaesth Intens Care, 9:324–328.
- Gillard M, Der Perren CV, Moguilevsky N, Massingham R, Chatelain P. (2002). Binding characteristics of cetirizine and levocetirizine to human h1 histamine receptors: contribution of Lys191 Aad Thr194. Mol Pharmacol, 61:391–399.
- Ng KH, Chong D, Wong CK, Ong HT, Lee CY, Lee BW, Shek LP. (2004). Central nervous system side effects of first- and second-generation antihistamines in school children with perennial allergic rhinitis: a randomized, double-blind, placebo-controlled comparative study. Pediatrics, 113:16–121.
- Braunstein G, Malaquin F, Fajac I, Melac M, Frossard N. (1992). Inhibition of histamine-induced nasal obstruction by cetirizine in allergic rhinitis. Br J Clin Pharmacol, 33:445–448.
- Li MH. (2003). The classification, pharmacology and clinical application of anti-allergic drugs. Chin J For Clin 31:15–18.
- Zhang Y. (2008). Determination of bergeninum and chlorphenamine maleate in compound bergeninum tablets by HPLC. China Pharma 17:25–26.
- Likar MD, Mansour HL, Harwood JW. (2005). Development and validation of a dissolution test for a once-a-day combination tablet of immediate-release cetirizine dihydrochloride and extended-release pseudoephedrine hydrochloride. J Pharm Biomed Anal 39:543–551.
- Wood-Baker R, Holgate ST. (1993). The comparative actions and adverse effect profile of single doses of H1-receptor antihistamines in the airways and skin of subjects with asthma. J Allergy Clin Immunol, 91:1005–1014.
- Kim MH, Lee SM, Lee SH, Kwon HS, Kim SH, Cho SH, Min KU, Kim YY, Chang YS. (2011). A case of chlorpheniramine maleate-induced hypersensitivity with aspirin intolerance. Allergy Asthma Immunol Res 3:62–64.
- Tadros MI. (2010). Controlled-release effervescent floating matrix tablets of ciprofloxacin hydrochloride: development, optimization and in vitro–in vivo evaluation in healthy human volunteers. Eur J Pharm Biopharm 74:332–339.
- Ls W, Pw H, Lf W. (1993). Relationship between swelling and drug release in a hydrophilic matrix drug. Dev Ind Pharm 19:1201–1210.
- Peppas NA. (1985). Analysis of Fickian and non-Fickian drug release from polymers. Pharm Acta Helv, 60:110–111.
- Guan J, Zhou L, Nie S, Yan T, Tang X, Pan W. (2010). A novel gastric-resident osmotic pump tablet: in vitro and in vivo evaluation. Int J Pharm 383:30–36.
- Akimotoet M, Nagahata M, Furuya A, Fukushima K, Higuchi S, Suwa T. (2000). Gastric pH profiles of beagle dogs and their use as an alternative to human testing. Eur J Pharm Biopharm 49: 99–102.
- Parviz M. (1998). Evaluation of gastrointestinal pH and gastric residence time via the Heidelberg radiotelemetry capsule: pharmaceutical application. Drug Dev Res 38:73–85.
- Sauzet C, Claeys-Bruno M, Nicolas M, Kister J, Piccerelle P, Prinderre P. (2009). An innovative floating gastro retentive dosage system: formulation and in vitro evaluation. Int J Pharm, 378:23–29.
- Kambaa M, Seta Y, Kusaia A, Ikedaa M, Nishimura K. (2000). A unique dosage form to evaluate the mechanical destructive force in the gastrointestinal tract. Int J Pharm 208:61–70.